Loss-of-function variants in SYNGAP1 have been identified in individuals from cohorts with intellectual disability (syndromic and non-syndromic), autism, and epileptic encephalopathy [4, 13–15]. This evidence concerns the gene SYNGAP1 and Epileptic encephalopathy.